1. Home
  2. STAF vs ENTO Comparison

STAF vs ENTO Comparison

Compare STAF & ENTO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • STAF
  • ENTO
  • Stock Information
  • Founded
  • STAF 2009
  • ENTO 2014
  • Country
  • STAF United States
  • ENTO United States
  • Employees
  • STAF N/A
  • ENTO N/A
  • Industry
  • STAF Professional Services
  • ENTO Biotechnology: Pharmaceutical Preparations
  • Sector
  • STAF Consumer Discretionary
  • ENTO Health Care
  • Exchange
  • STAF Nasdaq
  • ENTO Nasdaq
  • Market Cap
  • STAF 1.6M
  • ENTO 1.3M
  • IPO Year
  • STAF N/A
  • ENTO 2016
  • Fundamental
  • Price
  • STAF $1.54
  • ENTO $0.35
  • Analyst Decision
  • STAF
  • ENTO
  • Analyst Count
  • STAF 0
  • ENTO 0
  • Target Price
  • STAF N/A
  • ENTO N/A
  • AVG Volume (30 Days)
  • STAF 4.0M
  • ENTO 252.0K
  • Earning Date
  • STAF 08-12-2024
  • ENTO 09-24-2024
  • Dividend Yield
  • STAF N/A
  • ENTO N/A
  • EPS Growth
  • STAF N/A
  • ENTO N/A
  • EPS
  • STAF N/A
  • ENTO N/A
  • Revenue
  • STAF $180,258,000.00
  • ENTO N/A
  • Revenue This Year
  • STAF $1.94
  • ENTO N/A
  • Revenue Next Year
  • STAF $8.38
  • ENTO N/A
  • P/E Ratio
  • STAF N/A
  • ENTO N/A
  • Revenue Growth
  • STAF 4.69
  • ENTO N/A
  • 52 Week Low
  • STAF $1.08
  • ENTO $0.19
  • 52 Week High
  • STAF $7.60
  • ENTO $14.51
  • Technical
  • Relative Strength Index (RSI)
  • STAF 43.28
  • ENTO 36.88
  • Support Level
  • STAF $1.32
  • ENTO $0.28
  • Resistance Level
  • STAF $1.99
  • ENTO $0.46
  • Average True Range (ATR)
  • STAF 0.23
  • ENTO 0.05
  • MACD
  • STAF -0.07
  • ENTO 0.02
  • Stochastic Oscillator
  • STAF 20.90
  • ENTO 44.44

About STAF Staffing 360 Solutions Inc. (DE)

Staffing 360 Solutions Inc operates in the international staffing sector. It is engaged in the execution of an international buy-integrate-build process through the acquisition of domestic and international staffing organizations. The company operates through three Business Streams: Professional Staffing, Commercial Staffing, and Employer of Record. It primarily supports accounting and finance, information technology, engineering, administration, and commercial disciplines.

About ENTO Entero Therapeutics Inc. Common Stock

Entero Therapeutics Inc is a late clinical-stage biopharmaceutical company focused on the development of targeted, non-systemic therapies for gastrointestinal (GI) diseases. The company's programs address significant unmet needs in GI health and include: latiglutenase, a Phase 3-ready, potentially first-in-class, targeted, oral biotherapeutic for celiac disease; capeserod, a selective 5-HT4 receptor partial agonist for indications including gastroparesis; and adrulipase, a recombinant lipase enzyme designed to enable the digestion of fats and other nutrients in cystic fibrosis and chronic pancreatitis patients with exocrine pancreatic insufficiency.

Share on Social Networks: